 |
| Finance & Investments (World) |
 |
|
 |
NEW YORK, December 3 (newratings.com) - Analysts at Caris & Company reiterate their "average" rating on OmniVision (ticker: OVTI). The target price has been reduced from $6 to $4.5. [more]  |


NEW YORK, December 3 (newratings.com) - Analysts at Friedman Billings upgrade Bed Bath & Beyond (ticker: BBBY) from "underperform" to "market perform." The target price has been raised from $18 to $22. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at JMP Securities downgrade Beazer Homes (ticker: BZH) from "market underperform" to "market perform." [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Argus upgrade Pfizer (ticker: PFE) from "hold" to "buy." The target price is set to $20. [more]  |


NEW YORK, December 3 (newratings.com) - Analysts at BB&T Capital Markets initiate coverage of Quality Systems (ticker: QSII) with a "buy" rating. The target price is set to $42. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at UBS upgrade Darden Restaurants (ticker: DRI) from "neutral" to "buy." [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at JMP Securities reiterate their "market outperform" rating on OptionsXpress (ticker: OXPS). The target price has been reduced from $24 to $19. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Caris & Company reiterate their "below average" rating on Holly (ticker: HOC). The target price has been reduced from $21 to $16. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Boenning & Scattergood upgrade PNC Bank (ticker: PNC) from "market perform" to "market outperform." The target price is set to $53.5. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Citigroup upgrade Cintas (ticker: CTAS) from "sell" to "hold." The target price has been reduced from $27 to $24. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Barclays Capital reiterate their "equal weight" rating on Illinois Tool Works Inc (ticker: ITW). The target price has been reduced from $38 to $32. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Wachovia Securities upgrade RC2 (ticker: RCRC) from "market perform" to "outperform." [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at BMO Capital Markets downgrade Stryker (ticker: SYK) from "outperform" to "market perform." [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at BB&T Capital Markets initiate coverage of Objective Systems (ticker: OSII) with a "buy" rating. The target price is set to $42. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Barclays Capital reiterate their "equal weight" rating on Ingersoll-Rand Co Ltd (ticker: IR). The target price has been reduced from $24 to $18. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at JMP Securities reiterate their "market outperform" rating on Research In Motion (ticker: RIMM). The target price has been reduced from $80 to $55. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Barclays Capital reiterate their "overweight" rating on ITT Industries Inc (ticker: ITT). The target price has been reduced from $57 to $53. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at JMP Securities reiterate their "market outperform" rating on Vail Resorts (ticker: MTN). The target price has been reduced from $50 to $35. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Barclays Capital reiterate their "overweight" rating on Roper Industries Inc (ticker: ROP). The target price has been reduced from $52 to $50. [more]  |
NEW YORK, December 3 (newratings.com) - Analysts at Kaufman Bros reiterate their "hold" rating on Marvell (ticker: MRVL). The target price has been reduced from $8 to $6. [more]  |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 ... 25 » |
 |
|